Xylt2 Knockout Eliminates O‐Xylosylation and Enhances Bone Morphogenetic Protein 2 Production in Chinese Hamster Ovary Cells
Biotechnology Journal · 2026-06 · 21 (6)
DOI: 10.1002/biot.70256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 02.06.2026. Verfasst von Lin Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cell Line Development, WuXi Biologics, Shanghai, China. Hauptthemen laut MEDLINE: Pentosyltransferases, Bone Morphogenetic Protein 2. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
O‐xylosylation of glycine–serine (GS) linkers in multispecific antibodies or fusion proteins introduces product heterogeneity, posing critical challenges for biomanufacturing quality control and elevating potential immunogenicity risks. This post‐translational modification is primarily catalyzed by xylosyltransferase 2 ( Xylt2 ) in chinese hamster ovary (CHO) cells. To address this, we generated Xylt2 ‐deficient CHO cells via both clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated protein 9 (Cas9) and zinc finger nuclease (ZFN)‐mediated gene knockout, which resulted in the complete elimination of O‐xylosylation as verified by mass spectrometry in a GS linker‐containing bispecific antibody. Furthermore, because heparan sulfate proteoglycans (HSPGs), key cell‐surface receptors for ligand binding and internalization, rely on O‐xylosylation for their proper biosynthesis and function, the Xylt2 knockout also enhanced the titer of human bone morphogenetic protein 2 (hBMP2), which undergoes HSPG‐dependent cellular uptake, with up to a 2.5‐fold increase from 9.62 to 34.09 µg/mL in engineered cells compared to wild‐type CHO controls. Collectively, our results demonstrate that Xylt2 ‐deficient cell lines provide a genetic approach to produce recombinant proteins without O‐xylosylation, as well as for enhancing the titer of hBMP2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Line Development, WuXi Biologics, Shanghai, China.
- Bioprocess Research and Development, WuXi Biologics, Shanghai, China.
ORCID-Profile: Quanxue Li, Yu Zhang, Hang Zhou, Tao Sun
Zitieren
APA
Han, L., Wu, N., Li, Q., Li, Y., Zhang, Y., Chen, X., Zhou, H., Chen, F., & Sun, T. (2026). Xylt2 Knockout Eliminates O‐Xylosylation and Enhances Bone Morphogenetic Protein 2 Production in Chinese Hamster Ovary Cells. Biotechnology Journal, 21(6). https://doi.org/10.1002/biot.70256
Vancouver
Han L, Wu N, Li Q, Li Y, Zhang Y, Chen X, et al. Xylt2 Knockout Eliminates O‐Xylosylation and Enhances Bone Morphogenetic Protein 2 Production in Chinese Hamster Ovary Cells. Biotechnology Journal. 2026;21(6). doi:10.1002/biot.70256
BibTeX
@article{Han2026,
author = {Han, Lin and Wu, Nana and Li, Quanxue and Li, Ying and Zhang, Yu and Chen, Xiaoyue and Zhou, Hang and Chen, Fei and Sun, Tao},
title = {Xylt2 Knockout Eliminates O‐Xylosylation and Enhances Bone Morphogenetic Protein 2 Production in Chinese Hamster Ovary Cells},
journal = {Biotechnology Journal},
year = {2026},
volume = {21},
number = {6},
doi = {10.1002/biot.70256}
}
EUVIMED